| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access offsets poverty in quest for CAR T cells
|
Rouce, Rayne H.
|
|
|
141 |
6 |
p. 558-560
|
artikel
|
| 2 |
Acquired BAX mutations in AML
|
Kim, Won Jun
|
|
|
141 |
6 |
p. 562-564
|
artikel
|
| 3 |
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia
|
Moujalled, Donia M.
|
|
|
141 |
6 |
p. 634-644
|
artikel
|
| 4 |
Back Matter
|
|
|
|
141 |
6 |
p. II
|
artikel
|
| 5 |
Benjamin RJ. A conceptual framework for managing iTTP. Blood. 2021;137(14):1845-1846.
|
|
|
|
141 |
6 |
p. 682
|
artikel
|
| 6 |
Camaschella C. Iron deficiency. Blood. 2019;133(1):30-39.
|
|
|
|
141 |
6 |
p. 682
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
141 |
6 |
p. xiv
|
artikel
|
| 8 |
Flicking the switch in myeloma MRD
|
Watson, Edmund
|
|
|
141 |
6 |
p. 557-558
|
artikel
|
| 9 |
F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B
|
Liu, Guoqing
|
|
|
141 |
6 |
p. 677-680
|
artikel
|
| 10 |
Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes
|
Linder, Monika I.
|
|
|
141 |
6 |
p. 645-658
|
artikel
|
| 11 |
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy
|
Newman, Haley
|
|
|
141 |
6 |
p. 609-619
|
artikel
|
| 12 |
Masthead Subscription
|
|
|
|
141 |
6 |
p. III
|
artikel
|
| 13 |
Miller PG, Qiao D, Rojas-Quintero J, et al. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood. 2022;139(3):357-368.
|
|
|
|
141 |
6 |
p. 682
|
artikel
|
| 14 |
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials
|
Paiva, Bruno
|
|
|
141 |
6 |
p. 579-591
|
artikel
|
| 15 |
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effects
|
Patterson, Michael T.
|
|
|
141 |
6 |
p. 659-672
|
artikel
|
| 16 |
No pain, white gain?
|
Weinmann, Laurent
|
|
|
141 |
6 |
p. 681
|
artikel
|
| 17 |
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
|
Pemmaraju, Naveen
|
|
|
141 |
6 |
p. 567-578
|
artikel
|
| 18 |
Peritransplant CAR-T cells
|
Schmidts, Andrea
|
|
|
141 |
6 |
p. 564-566
|
artikel
|
| 19 |
Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells
|
Goldman, Adam
|
|
|
141 |
6 |
p. 673-677
|
artikel
|
| 20 |
Retinoid X receptor promotes hematopoietic stem cell fitness and quiescence and preserves hematopoietic homeostasis
|
Menéndez-Gutiérrez, María Piedad
|
|
|
141 |
6 |
p. 592-608
|
artikel
|
| 21 |
Table of Contents
|
|
|
|
141 |
6 |
p. xi-xiii
|
artikel
|
| 22 |
The genome of IMiD-refractory myeloma
|
Laganà, Alessandro
|
|
|
141 |
6 |
p. 560-561
|
artikel
|
| 23 |
Westin J, Sehn LH. CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift? Blood. 2022;139(18):2737-2746.
|
|
|
|
141 |
6 |
p. 683
|
artikel
|
| 24 |
Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma
|
Ansari-Pour, Naser
|
|
|
141 |
6 |
p. 620-633
|
artikel
|
| 25 |
Yu Y-T, Chang K-C. Immunoblastoid blastic plasmacytoid dendritic cell neoplasm with MYC rearrangement. Blood. 2022;139(14):2257.
|
|
|
|
141 |
6 |
p. 682
|
artikel
|
Tijdschrift beschrijving